Walleye Trading
ACAD icon

Walleye Trading’s Acadia Pharmaceuticals ACAD Stock Holding History

Walleye Trading’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,846
Closed -$183K – 4046
2025
Q4 		$183K Buy
+6,846
New +$164K ﹤0.01% 3443
2025
Q3 		– Sell
-10,624
Closed -$251K – 4310
2025
Q2 		$229K Buy
+10,624
New +$197K ﹤0.01% 3162
2023
Q4 		– Sell
-9,417
Closed -$225K – 5018
2023
Q3 		$196K Buy
+9,417
New +$256K ﹤0.01% 3612
2023
Q2 		– Sell
-18,061
Closed -$401K – 4654
2023
Q1 		$340K Buy
18,061
+5,325
+42% +$101K ﹤0.01% 3121
2022
Q4 		$203K Sell
12,736
-10,488
-45% -$164K ﹤0.01% 3562
2022
Q3 		$380K Buy
23,224
+18,742
+418% +$304K ﹤0.01% 3148
2022
Q2 		$63K Sell
4,482
-13,891
-76% -$259K ﹤0.01% 4255
2022
Q1 		$445K Sell
18,373
-10,876
-37% -$263K ﹤0.01% 3022
2021
Q4 		$683K Sell
29,249
-9,744
-25% -$196K ﹤0.01% 2627
2021
Q3 		$648K Buy
38,993
+20,292
+109% +$391K ﹤0.01% 2671
2021
Q2 		$456K Buy
+18,701
New +$422K ﹤0.01% 3024
2019
Q4 		– Sell
-9,426
Closed -$410K – 4186
2019
Q3 		$339K Buy
+9,426
New +$286K ﹤0.01% 2478
2017
Q3 		– Sell
-338
Closed -$9K – 4030
2017
Q2 		$9K Sell
338
-12,390
-97% -$369K ﹤0.01% 4256
2017
Q1 		$438K Buy
+12,728
New +$449K ﹤0.01% 2347
2016
Q3 		– Sell
-2,981
Closed -$101K – 4761
2016
Q2 		$97K Buy
+2,981
New +$99.8K ﹤0.01% 3531
2016
Q1 		– Sell
-4,875
Closed -$106K – 5251
2015
Q4 		$174K Buy
+4,875
New +$172K ﹤0.01% 2826

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Walleye Trading's ACAD Position: Q1 2026 in Review

Walleye Trading sold out of Acadia Pharmaceuticals (ACAD) in Q1 2026, closing a stake of 6,846 shares — an estimated $183K sold.

Walleye Trading first reported a position in ACAD in Q4 2015 and held it in 16 quarters. The position peaked at $683K in Q4 2021. 343 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Walleye Trading reported no remaining Acadia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 6,846 Acadia Pharmaceuticals shares in Q1 2026, an estimated $183K.
  • Walleye Trading first reported a position in Acadia Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • Walleye Trading's Acadia Pharmaceuticals position peaked at $683K in Q4 2021.
  • 343 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.